Sim Brandon 4

What Happened

• Sim Brandon, CEO and President of Astrana Health (ASTH), exercised stock options on February 2, 2026 to acquire 21,334 shares at an exercise price of $23.24 per share, for a total cash outlay of $495,802. The filing also reports the corresponding conversion/disposition of the derivative instrument tied to those options (reported at $0.00), which reflects the option-to-share conversion.

Key Details

• Transaction date: 2026-02-02.
• Transaction codes: M = option exercise (acquired 21,334 shares @ $23.24, $495,802); matching derivative disposition reported @ $0.00.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Timeliness: Filed 2026-02-03 for a 2026-02-02 transaction — appears timely (not reported late).
• Notable footnotes:
  • F5: The exercised options were fully vested and exercisable.
  • F1 & F2: Some reported securities are held in family/irrevocable trusts; Brandon Sim disclaims beneficial ownership except to the extent of pecuniary interest.
  • F3: The filing lists substantial unvested restricted stock and restricted stock units with vesting schedules (e.g., 29,919 shares vest 6/27/2026; multiple RSU tranches totaling over 200,000 units vesting semi‑annually beginning March–April 2026).
  • F4: Includes 1,420 shares from the employee stock purchase plan.

Context

• This was an option exercise to acquire shares (a purchase by the insider), not an immediate sale — not a cashless sell‑to‑cover in the reported lines. The separate zero‑dollar derivative disposition entry reflects conversion of the option instrument into common shares as part of the exercise. Per the footnotes, many holdings are held in trusts and he disclaims beneficial ownership beyond pecuniary interest; several significant equity awards remain unvested under set schedules.